IMTXW लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 01:30):
Our systems believe the stock currently is undervalued by 0.07% compare to its pairs and should correct upwards.

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States...

Stats
आज की मात्रा	1 302
औसत मात्रा	0
बाजार मूल्य	1.26B
EPS	$-0.0311 ( Q1 \| 2024-05-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0280 (0.93%)

AADI -2.65%

ABCL 1.46%

ABCM 0.04%

ABEO -2.84%

ABIO -1.68%

ABOS 1.40%

ABSI 3.07%

ABUS -2.24%

ABVX -3.53%

ACAD -0.38%

ACER -17.95%

ACET -4.76%

ACGN 1.29%

ACHL -3.00%

ACHV -1.72%

ACIU -1.00%

ACLX -0.06%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.91%

ADGI 0.87%

ADIL 0.54%

ADMA -2.63%

ADPT -0.30%

ADTX -3.47%

ADVM -4.34%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.58%

AGIO -2.04%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.39%

AKRO -2.85%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.26%

ALEC -3.90%

ALGS -2.41%

ALKS -0.19%

ALLK -8.47%

ALLO -6.39%

ALLR -3.17%

ALNA 3.16%

ALNY 1.77%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.50%

ALVR -0.58%

ALXN 0.00%

ALXO -10.96%

ALZN 4.78%

AMRN -0.31%

AMTI -3.13%

ANAB 0.50%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.63%

ANPC -3.15%

APGE -1.01%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.00%

APLT -4.28%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 3.27%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.84%

ARDS -14.23%

ARDX -0.66%

ARGX -0.81%

ARNA 0.00%

ARPO -0.90%

ARQT -0.57%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.64%

ARWR -1.86%

ASLN -4.71%

ASMB -7.14%

ASND -0.91%

ATAI -1.11%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 2.91%

ATRA -2.89%

ATXI 1.93%

ATXS -1.00%

AUPH -1.17%

AURA -0.15%

AUTL -1.58%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -5.17%

AVTX -1.25%

AVXL -2.71%

AXLA 0.00%

AXSM -1.75%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.81%

BCAB 3.59%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 7.14%

BCRX 1.15%

BCTX 7.61%

BCTXW -16.32%

BCYC 0.83%

BDRX -3.52%

BDTX -0.85%

BEAM 0.25%

BFRA -2.91%

BGNE -2.59%

BIOR -3.40%

BIVI 1.27%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.53%

BMEA -9.96%

BMRN 0.36%

BNOX -2.22%

BNTC -2.11%

BNTX -1.58%

BOLD -7.90%

BOLT 1.31%

BPMC -1.27%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 23.31%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.76%

CADL -0.97%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA 0.21%

CARM 12.13%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.90%

CCCC -5.42%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -3.10%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.00%

CDXS 4.84%

CELC -4.25%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.91%

CERO -3.40%

CEROW -10.18%

CFRX -27.95%

CGEM -2.50%

CGEN -2.79%

CGON -0.29%

CGTX -5.11%

CHMA -6.00%

CHRS -0.32%

CINC 0.00%

CING 2.56%

CINGW 34.95%

CKPT -2.88%

CLBS -16.75%

CLDX -2.26%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.02%

CLSD 1.60%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -8.03%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -40.05%

CNST 0.00%

CNTA -0.67%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -2.91%

CORT 2.31%

COYA -1.46%

CPRX -0.79%

CRBP -1.88%

CRBU -4.83%

CRDF -1.77%

CRGX 1.28%

CRIS -0.38%

CRNX -5.66%

CRSP 0.89%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.31%

CTNM -0.65%

CTXR 0.04%

CUE 3.81%

CVAC -2.26%

CVKD -5.23%

CWBR 2.80%

CYAD -12.96%

CYCC 9.75%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.00%

CYTO -2.73%

DARE 7.54%

DAWN 0.52%

DBTX -0.81%

DBVT 4.44%

DFFN 10.28%

DICE 0.06%

DMAC 32.74%

DNLI -1.61%

DNTH -6.31%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.51%

DTIL 1.36%

DYAI 9.68%

EARS -1.77%

EDIT -2.42%

EDSA -1.00%

EFTR 8.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.77%

ELOX 7.69%

ELTX -0.88%

ELVN -3.87%

ELYM 1.05%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.11%

ENTA -0.49%

ENTO -4.42%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.83%

ETON 1.68%

ETTX 0.00%

EVAX -2.14%

EVGN 3.88%

EVLO 0.00%

EWTX -0.06%

EXAI -0.94%

EXEL -0.36%

EYEG -0.69%

EYEN 1.48%

EYPT -0.12%

FATE -8.06%

FBIO 0.59%

FBIOP 0.92%

FBLG -15.20%

FBRX -0.04%

FDMT -4.73%

FENC -1.29%

FGEN -5.15%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.58%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.40%

FULC -3.18%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.29%

GANX -0.93%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.20%

GHRS -1.59%

GLMD -2.32%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -1.58%

GLYC -10.03%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 1.33%

GNPX 0.00%

GNTA 3.94%

GOSS -9.82%

GOVX 4.99%

GOVXW -49.04%

GPCR -6.49%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.08%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.16%

HALO -0.89%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.77%

HOOK 1.13%

HOTH -2.70%

HOWL -2.14%

HRMY 0.85%

HRTX 1.80%

HSTO 0.00%

HUMA 2.13%

HUMAW -0.01%

IBRX -4.41%

ICCC 0.22%

ICPT 0.21%

ICU 16.82%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.52%

IFRX -1.85%

IGMS -0.15%

IKNA 0.60%

IKT 1.42%

IMAB -0.58%

IMCR -2.61%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.90%

IMNM -1.56%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.70%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.66%

INAB 0.00%

INBX 0.46%

INCY -0.95%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.66%

INO -1.82%

INSM -0.85%

INTS -2.75%

INVA 0.25%

INZY 1.14%

IOBT -11.42%

IONS 0.34%

IOVA -2.31%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.81%

ISEE 0.38%

ITOS -1.44%

ITRM 1.67%

IVA 6.96%

IVVD -4.13%

JAGX 1.04%

JANX -4.02%

JAZZ -0.51%

JNCE 0.00%

JSPR -5.92%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.90%

KDNY 0.22%

KMPH -0.34%

KNSA -2.71%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.20%

KRRO -6.34%

KRTX 0.03%

KRYS -0.99%

KTRA 16.77%

KTTA 8.16%

KTTAW 0.92%

KURA -1.83%

KYMR -2.34%

KYTX -3.94%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -1.71%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.65%

LENZ -4.01%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -10.05%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -3.16%

LPTX -1.10%

LQDA -0.24%

LRMR -1.78%

LSTA -4.06%

LTRN 1.76%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -2.06%

LYEL -35.13%

LYRA 2.33%

MACK 0.10%

MBIO -9.22%

MBRX -1.72%

MCRB 1.37%

MDGL -2.42%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.97%

MGX -2.68%

MIRM -1.55%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.63%

MLYS -5.63%

MNKD -1.05%

MNMD 0.21%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -3.74%

MREO -4.14%

MRKR 2.68%

MRNA -4.99%

MRNS -4.04%

MRSN -2.62%

MRTX -0.17%

MRUS 0.18%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.24%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.14%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -2.03%

NKGN 5.88%

NKGNW 8.00%

NKTR -3.74%

NKTX -4.57%

NLSP -2.82%

NLSPW 26.67%

NMRA -0.91%

NMTR -42.97%

NOVN -24.84%

NRBO 12.11%

NRIX -0.29%

NRSN -7.05%

NRSNW 0.00%

NRXP -4.14%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.21%

NTRBW -31.07%

NUVL -2.00%

NVAX -2.17%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.26%

OABIW -10.06%

OBIO -2.99%

OBSV 0.00%

OCEA 0.00%

OCGN 4.24%

OCS -1.02%

OCUL -1.91%

OCUP 1.96%

ODT -4.27%

OKYO 1.51%

OLMA -5.54%

OMER -1.03%

OMGA 4.96%

ONCO 5.04%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 3.09%

ORGS -2.07%

ORIC -3.56%

ORMP 15.09%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -7.64%

PBYI 1.69%

PCSA 0.00%

PCVX -0.37%

PDSB -1.11%

PEPG -0.60%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.73%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 0.84%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.22%

PRQR -0.01%

PRTA -2.31%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -0.97%

PTCT -0.50%

PTE -0.82%

PTGX -1.70%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 2.29%

QLGN -3.67%

QNCX 5.70%

QNRX 0.37%

QSI -11.92%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -2.27%

RARE 1.10%

RCKT -8.17%

REGN -0.70%

RENB -3.42%

REPL -2.83%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.40%

RIGL -3.28%

RLAY -4.60%

RLMD 0.33%

RLYB -0.34%

RNA -0.46%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM 0.00%

RPRX 0.30%

RPTX -2.93%

RUBY 2.70%

RVLP -32.05%

RVMD -1.08%

RVMDW -30.00%

RVNC 1.91%

RVPH -1.58%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.36%

RYTM -6.37%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.56%

SANA -3.97%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.51%

SCPS 0.00%

SEEL -4.48%

SEER -0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.03%

SGMT -1.93%

SGTX -2.56%

SIOX 22.63%

SLDB -7.07%

SLGL 4.00%

SLN -4.21%

SLNO -3.74%

SLRX 6.69%

SLS -2.99%

SMMT -2.56%

SNDX 0.84%

SNGX -3.02%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.32%

SPRC -4.17%

SPRO 0.30%

SRNE -34.00%

SRPT -1.94%

SRRA 0.00%

SRRK -2.60%

SRZN -2.45%

STAB 0.00%

STOK -5.06%

STRO -2.18%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.16%

SWTX 0.41%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -6.99%

TARS 0.12%

TBPH 0.48%

TCBP 2.73%

TCDA 0.00%

TCON -2.03%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.23%

TENX -1.27%

TERN -7.70%

TFFP -3.05%

TGTX -2.94%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.16%

TNXP -6.39%

TNYA -8.23%

TPST 2.43%

TRDA -3.86%

TRVI 1.15%

TRVN 2.92%

TSHA -24.34%

TSVT -3.45%

TTNP -9.27%

TVTX 0.63%

TYRA -7.09%

UBX -2.12%

UNCY -3.73%

URGN -1.46%

UTHR -0.32%

VACC 11.36%

VALN -2.89%

VAXX 114.13%

VBIV 0.78%

VBLT -8.77%

VCEL -0.09%

VCNX 10.35%

VCYT -1.28%

VERA -2.81%

VERU 0.79%

VERV -3.06%

VIGL 5.11%

VINC 1.62%

VIR 0.06%

VIRI -1.57%

VIRX 2.40%

VKTX -1.63%

VLON -13.04%

VNDA -2.12%

VOR -2.02%

VRCA -0.07%

VRDN -4.31%

VRNA -1.40%

VRPX 0.38%

VRTX 0.35%

VSTM -3.74%

VTGN -0.45%

VTVT -2.97%

VTYX -0.21%

VXRT -2.59%

VYGR -1.66%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT 1.77%

XCUR 3.58%

XENE -3.11%

XERS 2.62%

XFOR 3.13%

XLO 2.00%

XLRN 0.00%

XNCR 0.47%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.51%

ZNTL -2.74%

ZSAN 0.00%

सहसंबंध (AI algo v.1.1b): Undervalued: 0.07% $3.00 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

immatics biotechnologies सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

immatics biotechnologies वित्तीय

Annual	2023
राजस्व:	$54.00M
सकल लाभ:	$-64.67M (-119.76 %)
EPS:	$-1.200

FY	2023
राजस्व:	$54.00M
सकल लाभ:	$-64.67M (-119.76 %)
EPS:	$-1.200

FY	2022
राजस्व:	$172.83M
सकल लाभ:	$66.05M (38.22 %)
EPS:	$0.550

Financial Reports:

No articles found.

immatics biotechnologies Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

immatics biotechnologies

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401, which is in Phase 1b clinical trial; and IMA402 and IMA403, which are in preclinical stages. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.